Food and Drug Administration / Toxicity Administration / U.S. Department of Health and Human Services Food and Drug Administration Center / Armed ServicesBlood Program Office / Division of Dockets Management / FDA’s Center for Biolagics Evaluation and Research / U.S. Army Medical and Material Command / International Committee on Harmonization / Department of Defense / Symptoms Administration / Cardiac Toxicity Administration / National Heart / Lung / and Blood Institute / office of Communication / Training and Manufacturers Assistance / /
Person
Toby Silverman / / /
Position
investigator / A. General / Governor / BACKGROUND DISCUSSION A. General / /
Guidance for In Criteria for Safety and E Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes DRAFT GUIDANCE This guidance is being distributed for comment purposes only.